Next Quarterly Earnings
Monday, March 8, 2027
Expected
Cosmo Pharmaceuticals is a specialty pharmaceutical company based in Ireland, focused on innovative therapies for gastroenterology and dermatology. The company develops and licenses advanced medicines and medical devices to improve patient care and address unmet needs in these therapeutic areas.
Cosmo Pharmaceuticals last reported quarterly earnings on 7/23/2026 (Q2 2026). Earnings per share (EPS) came in at 0.00 CHF.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.